tadalafil has been researched along with heptakis(2,6-o-dimethyl)beta-cyclodextrin in 1 studies
| Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (heptakis(2,6-o-dimethyl)beta-cyclodextrin) | Trials (heptakis(2,6-o-dimethyl)beta-cyclodextrin) | Recent Studies (post-2010) (heptakis(2,6-o-dimethyl)beta-cyclodextrin) |
|---|---|---|---|---|---|
| 1,742 | 392 | 1,089 | 148 | 0 | 45 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badr-Eldin, SM; Elkheshen, SA; Ghorab, MM | 1 |
1 other study(ies) available for tadalafil and heptakis(2,6-o-dimethyl)beta-cyclodextrin
| Article | Year |
|---|---|
Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Oral; beta-Cyclodextrins; Calorimetry, Differential Scanning; Carbolines; Chemistry, Pharmaceutical; Crystallography, X-Ray; Drug Compounding; Excipients; Freeze Drying; Kinetics; Phosphodiesterase Inhibitors; Solubility; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Tablets; Tadalafil; Technology, Pharmaceutical | 2008 |